- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 16/36 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
Patent holdings for IPC class C07K 16/36
Total number of patents in this class: 726
10-year publication summary
|
41
|
63
|
65
|
72
|
79
|
76
|
60
|
68
|
56
|
16
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Chugai Seiyaku Kabushiki Kaisha | 1319 |
47 |
| Genmab A/S | 406 |
28 |
| Novo Nordisk A/S | 2295 |
21 |
| Ablynx N.V. | 391 |
16 |
| CSL Behring GmbH | 342 |
16 |
| CSL Limited | 254 |
15 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3356 |
15 |
| Oregon Health & Science University | 757 |
14 |
| Takeda Pharmaceutical Company Limited | 2700 |
13 |
| Merus N.V. | 196 |
13 |
| Bayer Pharma AG | 1058 |
12 |
| Merck Sharp & Dohme LLC | 3724 |
12 |
| Novartis AG | 11042 |
10 |
| Adimab, LLC | 141 |
10 |
| Zymeworks Inc. | 243 |
10 |
| Rin Institute Inc. | 26 |
10 |
| Alexion Pharmaceuticals, Inc. | 619 |
9 |
| Aronora, Inc. | 15 |
9 |
| Fudan University | 661 |
9 |
| Kymab Limited | 250 |
9 |
| Other owners | 428 |